[Correspondence] Efficacy and safety of cannabinoids | ClinicLens
Jack Wilson and colleagues1 provide an important synthesis of randomised evidence on cannabinoids for mental and substance use disorders; their findings also highlight the limits of inferring real-world safety from trial-based adverse event data alone. The apparent absence of inc
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.